Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
Acq. completed
Consulting agrmnt
Employment agrmnt
|
|
Theriva Biologics, Inc. (SYN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 14,000 shares
@ $0.6931, valued at
$9.7k
|
|
| 06/07/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 26,000 shares
@ $0.6328, valued at
$16.5k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 25,000 shares
@ $0.9405, valued at
$23.5k
|
|
| 01/26/2023 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Theriva Biologics, Inc.|
Txns:
| Bought 25,000 shares
@ $0.873, valued at
$21.8k
|
|
| 01/23/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2021 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.3314, valued at
$66.3k
|
|
| 12/27/2021 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 650,000 options to buy
@ $0.3314, valued at
$215.4k
|
|
| 12/27/2021 |
4
| MONAHAN JOHN J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.3314, valued at
$66.3k
|
|
| 12/27/2021 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.3314, valued at
$66.3k
|
|
| 12/31/2020 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 150,000 options
@ $0.417, valued at
$62.6k
|
|
| 12/31/2020 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 450,000 options
@ $0.417, valued at
$187.7k
|
|
| 12/31/2020 |
4
| MONAHAN JOHN J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 150,000 options
@ $0.417, valued at
$62.6k
|
|
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Tarriff Scott (Former Director) has filed a Form 4 on Synthetic Biologics, Inc. |
| 12/06/2019 |
4
| Tarriff Scott (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 250,000 options
@ $0.418, valued at
$104.5k
|
|
| 12/06/2019 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 250,000 options
@ $0.418, valued at
$104.5k
|
|
| 12/05/2019 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 250,000 options
@ $0.418, valued at
$104.5k
|
|
| 12/05/2019 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 450,000 options
@ $0.418, valued at
$188.1k
|
|
| 08/26/2019 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Bought 50,000 shares
@ $0.4157, valued at
$20.8k
|
|
| 04/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2018 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 79,500 options
@ $0.6895, valued at
$54.8k
|
|
| 12/07/2018 |
4
| SHALLCROSS STEVEN A (CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options
@ $0.6895, valued at
$137.9k
|
|
| 12/07/2018 |
4
| Wolf Jeffrey Alan (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 79,500 options
@ $0.6895, valued at
$54.8k
|
|
| 12/07/2018 |
4
| Tarriff Scott (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 79,500 options
@ $0.6895, valued at
$54.8k
|
|
| 12/21/2017 |
4
| SHALLCROSS STEVEN A (Interim CEO and CFO) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 550,000 options
@ $0.52, valued at
$286k
|
|
| 12/21/2017 |
4
| Sliman Joseph A. (Chief Medical Officer) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 410,000 options
@ $0.52, valued at
$213.2k
|
|
| 12/21/2017 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options
@ $0.52, valued at
$104k
|
|
|
|
|